United States Pentasa Market Report 2016

This report studies sales (consumption) of Pentasa in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Ferring GmbH

Laboratórios Ferring Ltda

Shire US Inc.

Takeda’s Entyvio

Prescription Hope, Inc

GiCare

Treato

Prasco

 

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pentasa tablets

Pentasa granules

Type III

Split by applications, this report focuses on sales, market share and growth rate of  Pentasa in each application, can be divided into

Ulcerative colitis

Crohn’s disease

Application 3

 

Table of Contents

1 Pentasa Overview

1.1 Product Overview and Scope of Pentasa

1.2 Classification of Pentasa

1.2.1 Pentasa tablets

1.2.2 Pentasa granules

1.2.3 Type III

1.3 Application of Pentasa

1.3.1 Ulcerative colitis

1.3.2 Crohn’s disease

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pentasa (2011-2021)

1.4.1 United States Pentasa Sales and Growth Rate (2011-2021)

1.4.2 United States Pentasa Revenue and Growth Rate (2011-2021)

 

2 United States Pentasa Competition by Manufacturers

2.1 United States Pentasa Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Pentasa Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Pentasa Average Price by Manufactures (2015 and 2016)

2.4 Pentasa Market Competitive Situation and Trends

2.4.1 Pentasa Market Concentration Rate

2.4.2 Pentasa Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

 

3 United States Pentasa Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Pentasa Sales and Market Share by Type (2011-2016)

3.2 United States Pentasa Revenue and Market Share by Type (2011-2016)

3.3 United States Pentasa Price by Type (2011-2016)

3.4 United States Pentasa Sales Growth Rate by Type (2011-2016)

 

4 United States Pentasa Sales (Volume) by Application (2011-2016)

4.1 United States Pentasa Sales and Market Share by Application (2011-2016)

4.2 United States Pentasa Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

 

5 United States Pentasa Manufacturers Profiles/Analysis

5.1 Ferring GmbH

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Pentasa Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Ferring GmbH Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Laboratórios Ferring Ltda

5.2.2 Pentasa Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Laboratórios Ferring Ltda Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Shire US Inc.

5.3.2 Pentasa Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Shire US Inc. Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Takeda’s Entyvio

5.4.2 Pentasa Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Takeda’s Entyvio Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Prescription Hope, Inc

5.5.2 Pentasa Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Prescription Hope, Inc Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GiCare

5.6.2 Pentasa Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GiCare Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Treato

5.7.2 Pentasa Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Treato Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Prasco

5.8.2 Pentasa Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Prasco Pentasa Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

 

6 Pentasa Manufacturing Cost Analysis

6.1 Pentasa Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Pentasa

 

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Pentasa Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Pentasa Major Manufacturers in 2015

7.4 Downstream Buyers

 

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

 

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

 

10 United States Pentasa Market Forecast (2016-2021)

10.1 United States Pentasa Sales, Revenue Forecast (2016-2021)

10.2 United States Pentasa Sales Forecast by Type (2016-2021)

10.3 United States Pentasa Sales Forecast by Application (2016-2021)

10.4 Pentasa Price Forecast (2016-2021)

 

11 Research Findings and Conclusion

If you have any question for our report, please let us know!

Tina Ning
Tel: 0086-20-86655165
Email: tinaning@qyresearch.com
Website: http://www.qyresearcheurope.com/
Website: http://www.qyresearchglobal.com/

%d bloggers like this: